HPV Clinical Trial - Evaluation of Educational Interventions Targeting

Status Enrolling by invitation

Clinical Trial Summary

The goal of this clinical trial is to compare the effects of two different educational training programs on beliefs about Human Papillomavirus (HPV) in a group of female hospital employees. The main questions it aims to answer are: • Within the scope of the study, are the training programs provided to reduce misconceptions about HPV effective? • Which educational program is more effective in reducing misconceptions about HPV? Participants will • Complete a pre-test online the day before the first training date to determine the level of their misconceptions about HPV. • Receive informative messages via Whatsapp once a day for three days according to the training program they are assigned to. • Repeat the pre-test at the end of the training programs and one month later. • Receive the more effective training program after one month after the test repetition for the control group. Researchers will compare "Misbeliefs about HPV" and "Current Knowledge about HPV" titled training programs on reducing misconceptions about HPV.

Clinical Trial Description

The human papillomavirus (HPV) can cause health problems ranging from warts in the mouth or genital area to cervical, vaginal, vulvar, penile and anal cancers. Some beliefs about diseases or infectious agents have a negative impact on the early diagnosis and treatment of diseases, particularly by increasing the stigmatization effect of sexually transmitted diseases. Features such as the fact that mucosal contact is sufficient for transmission, that infected people can be symptom-free for a long time, that cancer often develops slowly, and that there are similarities with other sexually transmitted viruses such as HIV (human immunodeficiency virus) or herpes can have a negative impact on knowledge and beliefs about HPV. It is known that it is crucial to emphasize correct information, not to repeat or point out inaccuracies when taking action to combat false beliefs or myths. In the context of the COVID-19 pandemic, the importance of this approach has been frequently emphasized in the guidance contained in the confirmatory information on misinformation and disinformation. In our study, we want to compare the effectiveness of education models in which false beliefs or myths about HPV are conveyed before or after the current information. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06198491
Study type	Interventional
Source	Eskisehir Osmangazi University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	March 29, 2024
Completion date	May 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05736588` - Elimisha HPV (Human Papillomavirus)	N/A
Completed	`NCT01105000` - Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity
Recruiting	`NCT06147388` - Regression of Cervical Precancerous Lesions and Associated Risk Factors
Recruiting	`NCT04708470` - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers	Phase 1/Phase 2
Recruiting	`NCT06109870` - Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening	N/A
Completed	`NCT03082950` - HPV Infections, Cancer of the Vulva and Therapeutical Success
Recruiting	`NCT01512784` - Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults	Phase 3
Recruiting	`NCT05363709` - BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients	Phase 2
Completed	`NCT01231945` - Low-Cost Molecular Cervical Cancer Screening Study	N/A
Recruiting	`NCT01011712` - The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Recruiting	`NCT05996016` - Gut and Vaginal Microbiota Profile Study for HIV Women
Completed	`NCT05907187` - Research in Ethno-Medicine and Education (REMED)	N/A
Completed	`NCT05616767` - Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania	N/A
Completed	`NCT02247999` - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Terminated	`NCT01468636` - A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts	Phase 4
Active, not recruiting	`NCT04965792` - Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Active, not recruiting	`NCT05006833` - Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness	N/A
Enrolling by invitation	`NCT06120205` - SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening	N/A
Recruiting	`NCT05208710` - PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers	Early Phase 1
Completed	`NCT05462249` - Impact of Catch-up HPV Vaccination

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms